NO20063309L - Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt - Google Patents

Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt

Info

Publication number
NO20063309L
NO20063309L NO20063309A NO20063309A NO20063309L NO 20063309 L NO20063309 L NO 20063309L NO 20063309 A NO20063309 A NO 20063309A NO 20063309 A NO20063309 A NO 20063309A NO 20063309 L NO20063309 L NO 20063309L
Authority
NO
Norway
Prior art keywords
dimethylbenzylamino
pyridine
dimethyl
imidazo
hydroxyethyl
Prior art date
Application number
NO20063309A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Nordberg
Lars Liljequist
Maria Lindkvist
Ursula Pettersson
Tesfai Sebhatu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063309(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20063309L publication Critical patent/NO20063309L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20063309A 2003-12-18 2006-07-17 Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt NO20063309L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds
PCT/SE2004/001909 WO2005058895A1 (en) 2003-12-18 2004-12-16 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.

Publications (1)

Publication Number Publication Date
NO20063309L true NO20063309L (no) 2006-09-14

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063309A NO20063309L (no) 2003-12-18 2006-07-17 Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt

Country Status (24)

Country Link
US (1) US7459463B2 (pt)
EP (1) EP1697360B1 (pt)
JP (2) JP2007514744A (pt)
KR (1) KR20060125803A (pt)
CN (1) CN1894246B (pt)
AR (1) AR046956A1 (pt)
AT (1) ATE499371T1 (pt)
AU (1) AU2004299435B2 (pt)
BR (1) BRPI0417640A (pt)
CA (1) CA2549144A1 (pt)
CO (1) CO5721004A2 (pt)
DE (1) DE602004031556D1 (pt)
ES (1) ES2359829T3 (pt)
IL (1) IL175957A0 (pt)
MX (1) MXPA06006708A (pt)
MY (1) MY140450A (pt)
NO (1) NO20063309L (pt)
RU (1) RU2376306C2 (pt)
SE (1) SE0303451D0 (pt)
TW (1) TW200526659A (pt)
UA (1) UA84443C2 (pt)
UY (1) UY28676A1 (pt)
WO (1) WO2005058895A1 (pt)
ZA (1) ZA200604633B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060099524A (ko) * 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
MX2024005292A (es) 2021-11-05 2024-05-17 Cinclus Pharma Holding Ab Publ Polimorfos de la sal de clorhidrato de glurato de linaprazan.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE512531C2 (sv) 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100296D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100295D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
JP2004518709A (ja) 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
RS95304A (sr) * 2002-05-07 2006-12-15 Altana Pharma Ag. Nova kombinacija za tretman oboljenja disajnih puteva

Also Published As

Publication number Publication date
TW200526659A (en) 2005-08-16
MY140450A (en) 2009-12-31
UA84443C2 (ru) 2008-10-27
BRPI0417640A (pt) 2007-03-27
AU2004299435A1 (en) 2005-06-30
CN1894246B (zh) 2011-06-22
RU2006123362A (ru) 2008-01-27
US20070112021A1 (en) 2007-05-17
AR046956A1 (es) 2006-01-04
UY28676A1 (es) 2005-07-29
US7459463B2 (en) 2008-12-02
CA2549144A1 (en) 2005-06-30
EP1697360B1 (en) 2011-02-23
HK1095810A1 (en) 2007-05-18
SE0303451D0 (sv) 2003-12-18
ES2359829T3 (es) 2011-05-27
RU2376306C2 (ru) 2009-12-20
JP2012102143A (ja) 2012-05-31
WO2005058895A1 (en) 2005-06-30
CN1894246A (zh) 2007-01-10
KR20060125803A (ko) 2006-12-06
ZA200604633B (en) 2007-04-25
DE602004031556D1 (de) 2011-04-07
JP2007514744A (ja) 2007-06-07
EP1697360A1 (en) 2006-09-06
IL175957A0 (en) 2006-10-05
AU2004299435B2 (en) 2008-04-17
ATE499371T1 (de) 2011-03-15
MXPA06006708A (es) 2006-08-18
CO5721004A2 (es) 2007-01-31

Similar Documents

Publication Publication Date Title
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
NO20075169L (no) Nye imidazo (1,5-A)pyndindenvater, fremgangsmate for fremstilling og farmasoytiske sammensetninger som inneholder samme.
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
WO2004106279A3 (en) CRYSTALLINE FORM OF β2 ADRENERGIC RECEPTOR AGONIST
TW200613243A (en) Novel compounds
WO2007058832A3 (en) Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors
TW200730525A (en) Therapeutic agents
TW200420541A (en) Crystalline forms
WO2006053039A3 (en) Hydroxybenzoate salts of metanicotine compounds
EP4424370A3 (en) 7-phenoxy-n-(3-azabicyclo[3.2.1loctan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
NO20061363L (no) Pyrazolo- og imidazo- pyrimidinderivater
MXPA05010883A (es) Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina.
MX2024004146A (es) Metodo de sintesis del compuesto de furoimidazopiridina, forma de cristal del compuesto de furoimidazopiridina, y forma de cristal de la sal del mismo.
ES2340502T3 (es) Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad.
WO2004093805A3 (en) Selective spirocyclic glucocorticoid receptor modulators
NO20052124L (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
PT1869038E (pt) Compostos de 5,6,7,8-tetra-hidro-imidazo[1,2-a]piridin-2- ilamina substituída e sua utilização para produzir fármacos
NO20063309L (no) Nye krystallinske former av 2,3-dimetyl-8-(2,6-dimetylbenzylamino)-N-hydroksyetyl-imidazo[1,2-A]pyridin-6-karboksamid mesylatsalt
HUP0100019A2 (hu) A cipamfillin új polimorf formái, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
SE0100296D0 (sv) New compounds
SE0100297D0 (sv) New compounds
MX2024003444A (es) Compuestos de pirazolo[3,4-b]piridina para el tratamiento de enfermedades autoinmunitarias.
SE0100295D0 (sv) New compounds
NO20064988L (no) Ny krystallinsk form av 8-cyano-1-cyklopropyl-7-(1 S,6S-2,8-diazabicyklo[4.3 0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-okso-3-quinolinkarboksylsyre

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application